You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
安科生物(300009.SZ):新型冠狀病毒IgG/IgM抗體檢測試劑盒(膠體金法)獲歐盟CE認證
格隆匯 03-18 18:43

格隆匯3月18日丨安科生物(300009.SZ)公佈,2020年3月17日,公司產品新型冠狀病毒(COVID-19)IgG/IgM抗體檢測試劑盒(膠體金法)取得了歐盟CE認證。

中文名稱:新型冠狀病毒(COVID-19)IgG/IgM抗體檢測試劑盒(膠體金法),用途:用於體外快速定性檢測人血清、血漿和全血樣本中新型冠狀病毒(COVID-19)IgG/IgM抗體,輔助由新型冠狀病毒(COVID-19)感染引起的相關疾病的檢查。

新型冠狀病毒(SARS-CoV-2)IgG/IgM抗體檢測試劑盒(膠體金法)可檢測人血清、血漿及全血標本。針對疑似病例、密切接觸者、核酸檢測陰性者,特別是無症狀感染者能夠現場快速檢測,便於快速分流,較好的防止疫情擴散及滿足快速檢測的防控需求。

上述產品取得CE認證,表明該產品符合歐盟相關要求,已經具備歐盟市場的准入條件,體現了公司應對新型冠狀病毒疫情下的產品研發能力,將進一步提升公司的綜合競爭力,為新冠病毒疫情防控工作貢獻力量。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account